Get the Stockscreener App
24.58
0.16%
0.04
After Hours:
24.58
Integra Lifesciences Holdings Corp stock is traded at $24.58, with a volume of 235.48K.
It is up +0.16% in the last 24 hours and up +26.05% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$24.54
Open:
$24.59
24h Volume:
235.48K
Relative Volume:
0.25
Market Cap:
$1.90B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
20.31
EPS:
1.21
Net Cash Flow:
$60.93M
1W Performance:
+4.24%
1M Performance:
+26.05%
6M Performance:
-16.96%
1Y Performance:
-37.22%
1-Day Range:
$24.39
$24.87
1-Week Range:
$23.44
$24.87
52-Week Range:
$16.80
$45.42
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
24.58 | 1.90B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Victory Capital Management Inc. - Defense World
Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga
Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of chronic diseases to drive revenue, Report with AI-powered insightsTechnavio - The Malaysian Reserve
Integra Lifesciences (IART) Stock Dips Amid Financial Concerns - GuruFocus.com
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - Yahoo Finance
Fuller & Thaler Asset Management, Inc. Expands Stake in Integra Lifesciences Holdings Corp - GuruFocus.com
Capital Research Global Investors Reduces Stake in Integra Lifes - GuruFocus.com
Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
Integra LifeSciences : Serving Those Who Served - Marketscreener.com
Easterly Investment Partners LLC Has $1.12 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Leeward Investments LLC MA Has $6.83 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
Olstein Capital Management L.P. Has $2.82 Million Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Wound Dressing Market: Size, Share, Trends, and Global Analysis - openPR
Integra LifeSciences price target raised to $22 from $16 at Citi - Yahoo Finance
Louisiana State Employees Retirement System Sells 2,200 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
IART (Integra Lifesciences Holdings) PE Ratio without NRI : 8.77 (As of Nov. 05, 2024) - GuruFocus.com
Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure - MSN
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call Transcript - Insider Monkey
Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call - GuruFocus.com
Earnings call: Integra LifeSciences reports Q3 revenue decline, new CEO By Investing.com - Investing.com South Africa
Earnings call: Integra LifeSciences reports Q3 revenue decline, new CEO - Investing.com
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra Lifesciences names Mojdeh Poul as CEO - Yahoo Finance
Citi raises Integra LifeSciences target to $22, maintains sell rating - Investing.com
Why Is Integra LifeSciences Stock Soaring On Monday? - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Shares Gap UpHere's What Happened - MarketBeat
Integra Lifesciences Holdings Corp (IART) Shares Up 25.16% on No - GuruFocus.com
Q3 2024 Integra Lifesciences Holdings Corp Earnings Call Transcript - GuruFocus.com
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates - Yahoo Canada Finance
Integra: Q3 Earnings Snapshot - San Antonio Express-News
Integra Lifesciences Q3 Earnings: Revenue Beats at $380.8M, GAAP EPS Misses at $(0.14) - GuruFocus.com
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Potentially Undervalued? - Yahoo Finance
Integra LifeSciences Reports Third Quarter 2024 Financial Results - Yahoo Finance
Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer - Yahoo Finance
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Acquired by State of Alaska Department of Revenue - MarketBeat
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Repor - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Check Out Integra Lifesciences Holdings Corp (IART)’s Trade Data Rather Than the Analysts’ Views - SETE News
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 - Yahoo Finance
Integra Lifesciences Holdings Corp [IART] Investment Appeal on the Rise - Knox Daily
The Manufacturers Life Insurance Company Decreases Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Investor’s Delight: Integra Lifesciences Holdings Corp (IART) Closes Strong at 19.27, Up 6.46 - The Dwinnex
Integra Lifesciences Holdings Corp [IART] Records 200-Day SMA of $30.67 - Knox Daily
Integra Lifesciences Holdings Corp (IART) deserves deeper analysis - US Post News
Ultrasonic Aspirator Market Expected to Grow by USD 182.9 Million from 2024-2028, Driven by AI and Rising Neurological Disorder Cases - The Malaysian Reserve
Bank of America Cuts Integra LifeSciences (NASDAQ:IART) Price Target to $18.00 - MarketBeat
The Attractiveness of Investing In Integra Lifesciences Holdings Corp (IART) is Growing - Knox Daily
A look into Integra Lifesciences Holdings Corp (IART)’s deeper side - SETE News
Integra LifeSciences (NASDAQ:IART) Stock Rating Upgraded by BTIG Research - MarketBeat
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):